Search Results - "Symons‐Liguori, Ashley M"

Engagement of the GABA to KCC2 signaling pathway contributes to the analgesic effects of A3AR agonists in neuropathic pain by Ford, Amanda, Castonguay, Annie, Cottet, Martin, Little, Joshua W, Chen, Zhoumou, Symons-Liguori, Ashley M, Doyle, Timothy, Egan, Terrance M, Vanderah, Todd W, De Koninck, Yves, Tosh, Dilip K, Jacobson, Kenneth A, Salvemini, Daniela

“…More than 1.5 billion people worldwide suffer from chronic pain, yet current treatment strategies often lack efficacy or have deleterious side effects in…”
Get full text

Disease modification of breast cancer–induced bone remodeling by cannabinoid 2 receptor agonists by Lozano‐Ondoua, Alysia N, Hanlon, Katherine E, Symons‐Liguori, Ashley M, Largent‐Milnes, Tally M, Havelin, Josh J, Ferland, Henry L, Chandramouli, Anupama, Owusu‐Ankomah, Mabel, Nikolich‐Zugich, Tijana, Bloom, Aaron P, Jimenez‐Andrade, Juan Miguel, King, Tamara, Porreca, Frank, Nelson, Mark A, Mantyh, Patrick W, Vanderah, Todd W

“…Most commonly originating from breast malignancies, metastatic bone cancer causes bone destruction and severe pain. Although novel chemotherapeutic agents have…”
Get full text

Endogenous adenosine A3 receptor activation selectively alleviates persistent pain states by Little, Joshua W, Ford, Amanda, Symons-Liguori, Ashley M, Chen, Zhoumou, Janes, Kali, Doyle, Timothy, Xie, Jennifer, Luongo, Livio, Tosh, Dillip K, Maione, Sabatino, Bannister, Kirsty, Dickenson, Anthony H, Vanderah, Todd W, Porreca, Frank, Jacobson, Kenneth A, Salvemini, Daniela

“…Chronic pain is a global burden that promotes disability and unnecessary suffering. To date, efficacious treatment of chronic pain has not been achieved. Thus,…”
Get full text

Modulation of breast cancer cell viability by a cannabinoid receptor 2 agonist, JWH-015, is calcium dependent by Hanlon, Katherine E, Lozano-Ondoua, Alysia N, Umaretiya, Puja J, Symons-Liguori, Ashley M, Chandramouli, Anupama, Moy, Jamie K, Kwass, William K, Mantyh, Patrick W, Nelson, Mark A, Vanderah, Todd W

“…Cannabinoid compounds, both nonspecific as well as agonists selective for either cannabinoid receptor 1 (CB1) or cannabinoid receptor 2 (CB2), have been shown…”
Get full text

Pro‐osteolytic effects of chronic morphine administration in a model of breast cancer‐induced bone pain by Symons‐Liguori, Ashley M, Sayers, Nicole Marie, Vanderah, Todd W

“…Abstract only Many common cancers have a high propensity for bone metastasis; for breast cancer, bone metastasis affects 70% of advanced patients and is the…”
Get full text

Inflammatory signaling as a therapeutic target for the treatment of breast cancer‐induced bone pain by Sayers, Nicole Marie, Symons‐Liguori, Ashley M, Lozano‐Ondoua, Alysia N, Vanderah, Todd W

“…Abstract only Many common cancers, including breast, prostate, lung and kidney, have a high propensity for bone metastasis; for breast cancer, 70% of…”
Get full text

Engagement of the GABA to KCC2 Signaling Pathway Contributes to the Analgesic Effects of A 3 AR Agonists in Neuropathic Pain by Ford, Amanda, Castonguay, Annie, Cottet, Martin, Little, Joshua W., Chen, Zhoumou, Symons-Liguori, Ashley M., Doyle, Timothy, Egan, Terrance M., Vanderah, Todd W., De Koninck, Yves, Tosh, Dilip K., Jacobson, Kenneth A., Salvemini, Daniela

“…More than 1.5 billion people worldwide suffer from chronic pain, yet current treatment strategies often lack efficacy or have deleterious side effects in…”
Get full text

Engagement of the GABA to KCC2 Signaling Pathway Contributes to the Analgesic Effects of A sub(3)AR Agonists in Neuropathic Pain by d, Amanda, Castonguay, Annie, Cottet, Martin, Little, Joshua W, Chen, Zhoumou, Symons-Liguori, Ashley M, Doyle, Timothy, Egan, Terrance M, Vanderah, Todd W, De Konnick, Yves, Tosh, Dilip K, Jacobson, Kenneth A, Salvemini, Daniela

“…More than 1.5 billion people worldwide suffer from chronic pain, yet current treatment strategies often lack efficacy or have deleterious side effects in…”
Get full text